Biomarker Testing for Peptide Therapy
Peptide therapy without lab work is guesswork. Blood panels give your physician the objective floor and ceiling for every prescription — what dose is safe to start, when to titrate, and when to pause a course. This guide walks through the biomarkers PeptidesQ clinicians request at intake and how each one shapes protocol decisions.
The specific panel your reviewing physician orders depends on the protocol you apply for, your medical history, and any medications already on board. Every member's chart is reviewed by a licensed clinician before a prescription is written.
Why baseline labs come first
- Establish a floor. Without a baseline IGF-1, CMP, and CBC, later results have nothing to compare against — you can't tell a healthy response from an outlier.
- Surface silent contraindications. Uncontrolled hyperglycemia, elevated liver enzymes, low platelets, or an unrecognized thyroid disorder can change or block a peptide plan.
- Set stopping rules. Physicians define upfront which values would prompt dose reduction or pause — this is standard clinical governance, not overkill.
Panels PeptidesQ physicians commonly review
Growth hormone axis
- IGF-1 (with age/sex reference range). Primary readout for CJC-1295, ipamorelin, sermorelin, and tesamorelin protocols. Baseline plus 8–12 week follow-up to stay in the upper-normal range without exceeding it.
- IGFBP-3. Contextualizes IGF-1 bioavailability; useful when IGF-1 responses look blunted.
- Fasting glucose and insulin (HOMA-IR). GH-axis peptides can nudge insulin sensitivity; catch drift before it becomes a metabolic issue.
Metabolic and cardiovascular
- Comprehensive Metabolic Panel (CMP). Liver enzymes, kidney function, and electrolytes — required before any injectable peptide protocol.
- HbA1c. 3-month glycemic average; baseline for GLP-1, tirzepatide, and long-course GH peptide programs.
- Lipid panel (with ApoB when available). Track cardiometabolic response, especially on GLP-1s and BPC-157 long courses.
- hs-CRP. Low-grade inflammation marker; helpful for BPC-157, TB-500, and thymosin protocols.
Hematology and safety
- Complete Blood Count (CBC) with differential. Screens for anemia, infection, and platelet issues before injectables — and rules out red flags for thymosin alpha-1 candidates.
- PT / INR (when clinically indicated). Requested for members with bleeding history before BPC-157 or TB-500 initiation.
Hormonal and gonadal
- Total and free testosterone, SHBG, estradiol. Baseline for sexual health protocols (PT-141) and any peptide stack layered onto TRT.
- TSH, free T4, free T3. Rule out untreated thyroid disease before starting GH-axis or metabolic peptides.
- DHEA-S, morning cortisol. Contextualizes fatigue and stress-related symptoms during longevity workups.
Longevity and nutrient status
- Vitamin D (25-OH), B12, ferritin. Common correctable deficiencies that mimic peptide-responsive symptoms.
- Homocysteine. Cardiovascular and cognitive risk marker paired with methylation-focused protocols.
- GGT and uric acid. Sensitive markers for metabolic and hepatic strain during longer courses.
Cognitive and neuro protocols
- hs-CRP and homocysteine. Neuroinflammation and vascular risk context before dihexa or methylene blue courses.
- Fasting insulin and HbA1c. Insulin resistance is a modifiable driver of cognitive complaints — worth baselining.
How often should you re-test?
A common cadence for members on active protocols:
- Baseline before the first injection or capsule.
- 8–12 weeks for growth-hormone axis, GLP-1, and healing peptides to confirm response and screen for drift.
- Every 6 months for members on maintenance courses, with annual full panels for longevity protocols.
- Ad hoc whenever symptoms change materially or a new medication is added.
Bringing your own labs
If you already work with a primary care physician, endocrinologist, or longevity clinic, you can upload recent results during clinical intake. Panels drawn within the last 12 months are usually accepted for baseline; the reviewing physician will flag anything they'd like re-drawn before writing your protocol.
If you don't have current labs, your intake reviewer will send an order for the specific panel your protocol requires — you complete the draw at a partner lab and results flow back into your chart.
Ready to work with a physician who reads your labs?
PeptidesQ membership includes clinical review of every protocol and biomarker-driven adjustments over the course of care.